Clinical and biomarker data from a phase 1/2 trial of ifinatamab deruxtecan (I-DXd; DS-7300) in advanced solid tumors Meeting Abstract
| Authors: | Doi, T.; Patel, M. R.; Koyama, T.; Falchook, G. S.; Friedman, C.; Piha-Paul, S. A.; Gutierrez, M.; Awad, M.; Mattour, A.; Satoh, T.; Takahashi, S.; Tsunoda, T.; Kadowaki, S.; Watanabe, Y.; Okamoto, N.; Goto, H.; Yoshizuka, N.; Qian, M.; Qian, X.; Johnson, M. |
| Abstract Title: | Clinical and biomarker data from a phase 1/2 trial of ifinatamab deruxtecan (I-DXd; DS-7300) in advanced solid tumors |
| Meeting Title: | The Japanese Society of Medical Oncology Annual Meeting 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2024 Feb 22-24 |
| Meeting Location: | Nagoya, Japan |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-10-01 |
| Start Page: | S1315 |
| Language: | English |
| ACCESSION: | WOS:001345709300072 |
| DOI: | 10.1016/j.annonc.2024.07.717 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PS3-3 -- Source: Wos |
